Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial
- 31 December 2004
- journal article
- research article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 58 (10), 546-550
- https://doi.org/10.1016/j.biopha.2004.09.012
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Role of oxidative stress in atherosclerosisThe American Journal of Cardiology, 2003
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Therapeutic potential of anti-oxidants and diabetic retinopathyExpert Opinion on Investigational Drugs, 2001
- Xanthine oxidase-derived reactive oxygen metabolites contribute to liver necrosis: protection by 4-hydroxypyrazolo[3,4-d]pyrimidineBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2001
- Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathyExperimental and Clinical Endocrinology & Diabetes, 2000
- Increased Forearm Blood Flow During Glucose Clamp is Related Neither to Insulin Sensitivity nor to Hyperinsulinemia in Borderline Hypertensive Young menBlood Pressure, 1999
- Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and WhitesHypertension, 1997
- End-stage renal disease in African-American and white men. 16-year MRFIT findingsJAMA, 1997
- ENDOTHELIUM‐DERIVED HYPERPOLARIZING FACTORClinical and Experimental Pharmacology and Physiology, 1996
- Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.JCI Insight, 1994